Skip to main content

Novel Potentiators of Fluoroquinolones for Gram-negative Pathogens

Printer-friendly versionPrinter-friendly versionSend by emailSend by email
Award date: 
Jun 14, 2012
Award amount: 
$100,000
Organization name: 
UNC - Chapel Hill
Principal Investigator: 
Singleton, Scott F.
Grant program category: 
Research and Equipment Support
Grant program name: 
Collaborative Funding Grant
Region: 
Research Triangle

Synereca Pharmaceuticals has identified small molecule inhibitors of DNA repair that enhance killing by fluoroquinolone antibiotics. Synereca will develop these inhibitors and demonstrate their utility in crucial in vivo infection models. The pharmacologic proof of concept will enhance Synereca's ability to attract partners and investors.

Fiscal year: 
2012